Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
FRAMINGHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2023.
- FRAMINGHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2023.
- Fourth Quarter 2023 Financial Highlights:
Revenue was $65.9 million, an increase of 9% from $60.6 million in Q4 2022. - Full Year 2023 Financial Highlights:
Revenue was $251.4 million for the year, an increase of 13% from $222.7 million for the full year 2022. - Definitive Healthcare will host a conference call on February 28, 2024, at 5:00 p.m. (Eastern Time) to discuss the Company's full financial results and current business outlook.